Endocrine therapy with accelerated Partial breast irradiatiOn or exclusive ultra-accelerated Partial breast irradiation for women aged >= 60 years with Early-stage breast cancer (EPOPE): The rationale for a GEC-ESTRO randomized phase III-controlled trial

Hannoun-Levi JM, Chamorey E, Boulahssass R, Polgar C, Strnad V (2021)

Publication Type: Journal article

Publication year: 2021

Journal

Clinical and Translational Radiation Oncology Elsevier

Book Volume: 29

Pages Range: 1-8

DOI: 10.1016/j.ctro.2021.04.005

Abstract

Purpose: Breast cancer in the elderly has become a public health concern; there is a need to re-design its treatment with a view to de-escalation. Our paper sets out the rationale for a phase 3 randomized trial to evaluate less burdensome adjuvant procedures that remain effective and efficient.

Authors with CRIS profile

Vratislav Strnad Department of Radiation Oncology

Involved external institutions

University of Côte d'Azur / Université Côte d'Azur FR France (FR) Semmelweis University / Semmelweis Egyetem HU Hungary (HU)

How to cite

APA:

Hannoun-Levi, J.-M., Chamorey, E., Boulahssass, R., Polgar, C., & Strnad, V. (2021). Endocrine therapy with accelerated Partial breast irradiatiOn or exclusive ultra-accelerated Partial breast irradiation for women aged >= 60 years with Early-stage breast cancer (EPOPE): The rationale for a GEC-ESTRO randomized phase III-controlled trial. Clinical and Translational Radiation Oncology, 29, 1-8. https://doi.org/10.1016/j.ctro.2021.04.005

MLA:

Hannoun-Levi, Jean-Michel, et al. "Endocrine therapy with accelerated Partial breast irradiatiOn or exclusive ultra-accelerated Partial breast irradiation for women aged >= 60 years with Early-stage breast cancer (EPOPE): The rationale for a GEC-ESTRO randomized phase III-controlled trial." Clinical and Translational Radiation Oncology 29 (2021): 1-8.

BibTeX: Download